NYSE:ABC - AmerisourceBergen Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $128.25
Forecasted Upside: 5.72 %
Number of Analysts: 11
Breakdown:
0 Sell Ratings
4 Hold Ratings
7 Buy Ratings
0 Strong Buy Ratings

^$121.31 As of 07/23/2021 01:00 AM ET

▲ +1.47 (1.23%)

1 month | 3 months | 12 months

Get New AmerisourceBergen Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for ABC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABC

^$128.25

▲ +5.72% Upside Potential

This price target is based on 11 analysts offering 12 month price targets for AmerisourceBergen in the last 3 months. The average price target is $128.25, with a high forecast of $150.00 and a low forecast of $112.00. The average price target represents a 5.72% upside from the last price of $121.31.

Current Consensus is Buy

The current consensus among 11 contributing investment analysts is to buy stock in AmerisourceBergen. This rating has held steady since January 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
3 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/30/2020

0 strong buy ratings
5 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

4/29/2020

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

7/28/2020

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

10/26/2020

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

1/24/2021

0 strong buy ratings
6 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

4/24/2021

0 strong buy ratings
7 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

6/23/2021

0 strong buy ratings
7 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/23/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/20/2021	Robert W. Baird	Reiterated Rating	Buy		Medium
5/6/2021	Barclays	Boost Price Target	Equal Weight	$122.00 ➝ $130.00	Low
2/9/2021	Mizuho	Boost Price Target	Neutral	$104.00 ➝ $114.00	Low
2/8/2021	Morgan Stanley	Boost Price Target	Overweight	$130.00 ➝ $138.00	Medium
2/8/2021	Cowen	Boost Price Target	Outperform	$145.00 ➝ $150.00	Low
2/5/2021	Credit Suisse Group	Boost Price Target	Outperform	$123.00 ➝ $127.00	Low
2/4/2021	Evercore ISI	Upgrade	In-Line ➝ Outperform		Low
2/1/2021	Cowen	Boost Price Target	Outperform	$129.00 ➝ $145.00	Low
1/21/2021	Argus	Boost Price Target	Buy	$120.00 ➝ $140.00	Medium
1/7/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$111.00 ➝ $115.00	N/A
1/6/2021	Bank of America	Upgrade	Underperform ➝ Neutral		N/A
11/13/2020	Mizuho	Boost Price Target	Neutral	$100.00 ➝ $104.00	Medium
11/9/2020	Credit Suisse Group	Boost Price Target	Outperform	$118.00 ➝ $123.00	Low
11/9/2020	Morgan Stanley	Boost Price Target	Overweight	$121.00 ➝ $130.00	Low
11/6/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$104.00 ➝ $111.00	Low
8/10/2020	UBS Group	Boost Price Target	Buy	$99.00 ➝ $112.00	Low
8/10/2020	Credit Suisse Group	Boost Price Target	Outperform	$111.00 ➝ $118.00	Low
8/6/2020	Morgan Stanley	Boost Price Target	Overweight	$112.00 ➝ $121.00	High
7/21/2020	Bank of America	Boost Price Target	Underperform	$85.00 ➝ $88.00	Medium
6/15/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$94.00 ➝ $112.00	Medium
5/15/2020	UBS Group	Lower Price Target	Buy	$108.00 ➝ $99.00	High
5/11/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$93.00 ➝ $98.00	Medium
5/8/2020	Morgan Stanley	Boost Price Target	Equal Weight	$84.00 ➝ $94.00	High
4/22/2020	Credit Suisse Group	Initiated Coverage	Buy	$105.00	Low
4/1/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$93.00 ➝ $106.00	Medium
3/27/2020	Morgan Stanley	Lower Price Target	Equal Weight	$98.00 ➝ $84.00	Medium
2/7/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$112.00	Medium
2/2/2020	Credit Suisse Group	Reiterated Rating	Buy	$98.00	Low
1/31/2020	Robert W. Baird	Boost Price Target	Neutral	$93.00 ➝ $94.00	High
1/31/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$79.00 ➝ $93.00	High
1/19/2020	Barclays	Reiterated Rating	Hold	$100.00	Low
11/18/2019	Argus	Reiterated Rating	Buy	$110.00	Low
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$91.00	High
9/6/2019	Morgan Stanley	Lower Price Target	Equal Weight	$91.00 ➝ $83.00	N/A
6/3/2019	Argus	Lower Price Target	Buy	$115.00 ➝ $100.00	Medium
4/11/2019	Guggenheim	Initiated Coverage	Buy		Low
4/10/2019	Bank of America	Downgrade	Buy ➝ Underperform	$95.00 ➝ $76.00	High
4/2/2019	Wolfe Research	Initiated Coverage	Market Perform		High
1/17/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$89.00	Medium
1/6/2019	Barclays	Reiterated Rating	Hold	$84.00	Low
12/3/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$88.00 ➝ $91.00	Low
11/30/2018	Royal Bank of Canada	Lower Price Target	Sector Perform ➝ Hold	$90.00 ➝ $87.00	Low
11/7/2018	Royal Bank of Canada	Set Price Target	Hold	$90.00	Low
9/19/2018	Mizuho	Reiterated Rating	Neutral		Medium
8/12/2018	Mizuho	Reiterated Rating	Hold	$90.00	Low
8/3/2018	Robert W. Baird	Reiterated Rating	Hold	$89.00	Medium
7/20/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		Low
7/20/2018	Robert W. Baird	Reiterated Rating	Outperform ➝ Neutral	$94.00	Low
7/3/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$97.00 ➝ $88.00	Low
4/2/2018	Royal Bank of Canada	Set Price Target	Hold	$101.00	Medium
3/27/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$104.00 ➝ $95.00	Low
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$104.00	Low
3/5/2018	Argus	Boost Price Target	Buy	$93.96 ➝ $115.00	Low
2/27/2018	Cowen	Reiterated Rating	Buy	$108.00	Low
2/27/2018	Bank of America	Initiated Coverage	Buy ➝ Buy	$111.00	High
2/8/2018	Needham & Company LLC	Lower Price Target	Buy ➝ Buy	$117.00 ➝ $113.00	Medium
2/7/2018	Jefferies Financial Group	Set Price Target	Hold	$95.00	Medium
2/7/2018	Credit Suisse Group	Reiterated Rating	Outperform ➝ Outperform	$105.00 ➝ $112.00	Medium
2/7/2018	Royal Bank of Canada	Reiterated Rating	Hold	$102.00	Medium
1/24/2018	Mizuho	Set Price Target	Hold	$100.00	Low
1/23/2018	Needham & Company LLC	Boost Price Target	Buy ➝ Buy	$88.00 ➝ $108.00	Low
1/4/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$105.00	Medium
1/2/2018	SVB Leerink	Set Price Target	Buy	$90.00 ➝ $105.00	Low
12/15/2017	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy		High
12/12/2017	Cowen	Set Price Target	Buy	$107.00	Low
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$97.00	High
12/1/2017	Robert W. Baird	Set Price Target	Buy	$99.00	High
11/22/2017	Needham & Company LLC	Boost Price Target	Buy	$86.00 ➝ $88.00	N/A
11/6/2017	Robert W. Baird	Reiterated Rating	Buy	$96.00	N/A
11/6/2017	Needham & Company LLC	Lower Price Target	Buy	$93.00 ➝ $86.00	N/A
10/29/2017	Jefferies Financial Group	Set Price Target	Hold	$85.00	N/A
10/24/2017	Mizuho	Set Price Target	Hold	$92.00	N/A
10/24/2017	Needham & Company LLC	Set Price Target	Buy	$93.00	N/A
10/10/2017	Cowen	Upgrade	Market Perform ➝ Outperform		N/A
10/5/2017	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$89.00 ➝ $96.00	N/A
9/19/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$87.00	Medium
9/14/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight		High
9/10/2017	Needham & Company LLC	Reiterated Rating	Buy	$91.00	Medium
8/29/2017	Jefferies Financial Group	Set Price Target	Hold	$95.00	Low
8/7/2017	SVB Leerink	Set Price Target	Outperform ➝ Buy	$100.00 ➝ $90.00	Low
8/4/2017	UBS Group	Lower Price Target	Neutral ➝ Neutral	$94.00 ➝ $87.00	Low
7/13/2017	Credit Suisse Group	Reiterated Rating	Outperform ➝ Buy	$95.00	Low
6/30/2017	Bank of America	Downgrade	Buy ➝ Neutral	$95.76 ➝ $94.00	Medium
6/21/2017	Jefferies Financial Group	Reiterated Rating	Hold	$95.00	Low
5/30/2017	Mizuho	Boost Price Target	Neutral ➝ Neutral	$83.00 ➝ $93.00	Low
5/17/2017	Jefferies Financial Group	Initiated Coverage	Hold ➝ Hold	$95.00	High
4/4/2017	Needham & Company LLC	Initiated Coverage	Buy ➝ Buy	$99.00	Low
2/5/2017	Credit Suisse Group	Reiterated Rating	Buy		N/A
1/31/2017	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight		N/A
1/17/2017	SVB Leerink	Upgrade	Market Perform ➝ Outperform	$95.00	N/A
1/12/2017	Bank of America	Upgrade	Neutral ➝ Buy	$94.00	N/A
1/3/2017	Mizuho	Downgrade	Buy ➝ Neutral	$83.00	N/A
11/10/2016	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$84.00 ➝ $86.00	N/A
11/9/2016	Mizuho	Upgrade	Neutral ➝ Buy	$83.00	N/A
11/4/2016	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$75.00	N/A
10/10/2016	Cleveland Research	Downgrade	Buy ➝ Neutral		N/A
10/7/2016	SVB Leerink	Reiterated Rating	Buy	$100.00	N/A
10/5/2016	UBS Group	Initiated Coverage	Neutral		N/A
10/4/2016	Avondale Partners	Upgrade	Market Perform ➝ Outperform		N/A
9/12/2016	Morgan Stanley	Reiterated Rating	Hold	$89.00	N/A
8/26/2016	Credit Suisse Group	Reiterated Rating	Buy	$98.00	N/A
8/26/2016	SVB Leerink	Boost Price Target	Outperform	$100.00	N/A
8/11/2016	Mizuho	Boost Price Target	Neutral	$80.00 ➝ $90.00	N/A
8/3/2016	SVB Leerink	Reiterated Rating	Buy		N/A
8/3/2016	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$83.00 ➝ $96.00	N/A
8/3/2016	Citigroup	Boost Price Target	Buy	$100.00 ➝ $105.00	N/A
8/3/2016	Barclays	Boost Price Target	Equal Weight	$83.00 ➝ $89.00	N/A
8/3/2016	(FBRC)	Boost Price Target	Mkt Perform	$84.00 ➝ $90.00	N/A
8/2/2016	Evercore ISI	Reiterated Rating	Hold	$93.50	N/A

(Data available from 7/24/2016 forward)

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Today's Range

Now: $121.31

$119.91

$122.56

50 Day Range

MA: $116.51

$112.60

$121.31

52 Week Range

Now: $121.31

$92.00

$125.86

Volume

955,692 shs

Average Volume

1,108,957 shs

Market Capitalization

$24.92 billion

P/E Ratio

N/A

Dividend Yield

1.47%

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of AmerisourceBergen?

The following equities research analysts have issued reports on AmerisourceBergen in the last year: Argus, Bank of America Co., Barclays PLC, Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Mizuho, Morgan Stanley, Robert W. Baird, TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for ABC.

What is the current price target for AmerisourceBergen?

8 Wall Street analysts have set twelve-month price targets for AmerisourceBergen in the last year. Their average twelve-month price target is $128.25, suggesting a possible upside of 5.4%. Cowen Inc has the highest price target set, predicting ABC will reach $150.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $112.00 for AmerisourceBergen in the next year.
View the latest price targets for ABC.

What is the current consensus analyst rating for AmerisourceBergen?

AmerisourceBergen currently has 4 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABC will outperform the market and that investors should add to their positions of AmerisourceBergen.
View the latest ratings for ABC.

What other companies compete with AmerisourceBergen?

Other companies that are similar to AmerisourceBergen include McKesson, Cardinal Health, Henry Schein, Owens & Minor and Patterson Companies.

How do I contact AmerisourceBergen's investor relations team?

AmerisourceBergen's physical mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company's listed phone number is 610-727-7000 and its investor relations email address is [email protected] The official website for AmerisourceBergen is www.amerisourcebergen.com.